Distalmotion announces Frank Schulkes as new board member

“We are pleased to welcome Frank Schulkes to the Distalmotion Board of Directors,” said Rick Anderson. “Frank is a global leader in scaling public companies in medical devices with 25 years of deep capital equipment, service and consumable product experience from leading medical device companies. He has also been appointed chair of the audit committee for the board. Frank will play a key role in driving forward the company’s ultimate goal: establishing on-demand robotics as a new and improved standard of care for minimally invasive surgery in the abdomen.”

This addition to the Board of Directors follows the closing of a USD 90 million Series E financing round earlier this year and reinforces Distalmotion’s capabilities to fast-track its commercial development. With his broad and deep operational finance expertise, Frank Schulkes will also play a key role in building operational and regulatory systems to support Distalmotion’s submission to the FDA.

“I am delighted to join Distalmotion, one of the most exciting MedTech stories at the moment,” added Frank Schulkes. “Dexter stands for a paradigm shift in robotic surgery, as the only platform that manages to simplify robotics. Dexter makes robotics more user-friendly, versatile and affordable, thereby unlocking improved treatment options for patients. I look forward to supporting Distalmotion in these exciting times.”

“Welcoming a board member of such caliber is a very powerful signal to the industry, and we are delighted to have Frank support our fast scale-up and international roll-out,” said Michael Friedrich, CEO of Distalmotion. “We are in an exciting phase of our development and I’m looking forward to welcoming Frank in Lausanne, at our headquarter more often.”

Press release – EN – Distalmotion announces Frank Schulkes as new board member
To meet Dexter: distalmotion.com/meetdexter/schedulemeeting/
For press inquiries: press@distalmotion.com